Right Remedies Maximum Strength Nighttime Sleep-aid Softgel Capsule, Liquid Filled
NDC Package 70692-834-71
Package Information
Right Remedies Maximum Strength Nighttime Sleep-aid Softgel (diphenhydramine hydrochloride) capsules is adults and children 12 years and over take 1 softgel (50mg) at bedtime if needed, or as directed by a doctorchildren under 12 years do not use. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Strive Pharmaceuticals Inc., this product is identified by NDC 70692-834 and is authorized under FDA application M010.
Identification & Billing
- RxCUI: 1020477 - diphenhydrAMINE HCl 50 MG Oral Capsule
- RxCUI: 1020477 - diphenhydramine hydrochloride 50 MG Oral Capsule
- RxCUI: 1020477 - diphenhydramine HCl 50 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70692 - Strive Pharmaceuticals Inc.
- 70692-834 - Right Remedies Maximum Strength Nighttime Sleep-aid Softgel
- 70692-834-71 - 275 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 70692-834 - Right Remedies Maximum Strength Nighttime Sleep-aid Softgel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70692-834-71 identifies a specific commercial package of 275 capsule, liquid filled in 1 bottle of Right Remedies Maximum Strength Nighttime Sleep-aid Softgel, a human over the counter drug labeled by Strive Pharmaceuticals Inc.. This capsule, liquid filled is formulated for oral use and contains diphenhydramine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Strive Pharmaceuticals Inc. on March 19, 2025. The current certification is valid through December 31, 2026.
How is this Strive Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692083471. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.